Gradient-Echo MRI in Defining the Severity of Cerebral Fat Embolism by Lee, Jun
 
 
 
 
 
CASE REPORT 
164 Copyright ⓒ  2008 Korean Neurological Association
Print  ISSN 1738-6586 / On-line  ISSN 2005-5013
10.3988/jcn.2008.4.4.164 J Clin Neurol 2008;4:164-166   
 
Gradient-Echo MRI in Defining the Severity 
of Cerebral Fat Embolism 
 
Jun Lee, MD 
Department of Neurology, Yeungnam University School of Medicine, Daegu, Korea 
 
Received  April  21,  2008 
Revised   August 25, 2008 
Accepted  August  25,  2008 
 
Correspondence 
Jun Lee, MD 
Department of Neurology, 
Yeungnam University   
School of Medicine, 
317-1 Daemyeong-dong, Nam-gu, 
Daegu 705-717, Korea 
Tel +82-53-620-3680 
Fax +82-53-627-1688 
E-mail  junlee@ynu.ac.kr   
 
BackgroundᄏA few studies have found that abnormal findings on diffusion-weighted mag-
netic resonance imaging (MRI) are useful for diagnosing cerebral fat embolism in the acute 
stage. 
Case ReportᄏWe applied serial MRI to a case of cerebral fat embolism with cognitive im-
pairment lasting for 2 months. Although marked resolution of the previous abnormal findings 
was demonstrated, T2*-weighted gradient-echo MRI revealed multiple tiny lesions. 
ConclusionsᄏWe suggest that T2*-weighted gradient-echo MRI is useful in defining the cli-
nical severity of patients with cerebral fat embolism.  J Clin Neurol 2008;4:164-166
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Introduction 
 
Cerebral fat embolism is an uncommon but serious compli-
cation of long-bone fractures. Although such embolisms are 
diagnosed on the basis of clinical manifestations accompani-
ed by hypoxemia, neurologic dysfunction, and petechiae, their 
neurologic symptoms are variable and often nonspecific. 
There are several reports of magnetic resonance imaging 
(MRI) being a useful diagnostic tool for assessing cerebral 
fat embolism,
1,2 with a few reports emphasizing that abnor-
mal findings on diffusion-weighted MRI (DWI) have signi-
ficant diagnostic value in acute cerebral fat embolism.
3,4 The 
pathogenesis of disruption of the blood-brain barrier by ce-
rebral fat embolism is still unclear, but it is thought that fat 
globules occlude the microvasculature, producing necrosis 
and hemorrhage in the surrounding parenchyma.
5 Local in-
flammatory and toxic reactions by free fatty acid causes 
breakdown of the blood-brain barrier.
6 Considering that the 
pathologic findings in cerebral fat embolism are characteriz-
ed by multiple petechiae and purpura, and that T2*-weighted 
gradient-echo MRI is a sensitive method for detecting resi-
dual hemorrhage, this MRI sequence might aid the diagnosis 
of cerebral fat embolism.   
To the best of our knowledge, no previous study has em-
phasized the diagnostic usefulness of gradient-echo MRI in 
patients with cerebral fat embolism. This report presents a 
patient with cerebral fat embolism documented by the pre-
sence of multiple low signals on T2*-weighted gradient-echo 
MRI, in whom there was marked resolution of the previous 
abnormal findings. 
 
Case Report 
 
A 54-year-old male suffered from bilateral femoral fractures 
due to a traffic accident. He was alert and well oriented on 
admission, but became stuporous with extensor posturing 36 
hours after the accident. The findings of basic blood tests, 
including arterial blood gas, were normal, and the findings of 
chest X-rays were also unremarkable. Brain computer tomo-
graphy (CT) performed 3 hours after the deterioration showed 
normal findings. MRI was performed 10 hours later, with 
DWI, T2-weighted imaging (T2WI), and fluid-attenuated in-
version recovery (FLAIR) images showing multiple high-
signal lesions in the bilateral hemisphere. 
Multiple lesions were prominent in the subcortical and deep 
white matter. Other lesions were observed in the thalamus, 
basal ganglia, corpus callosum, and occipital cortex (Fig. 1). 
Electrocardiography and echocardiography showed normal 
findings. Three days later, multiple petechiae were detected 
on the skin of the anterior chest.    
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The patient received supportive therapy, and his condition 
improved slowly. Neuropsychologic testing was not possible 
due to poor cooperation from the patient. His severe cogni-
tive impairment, which included disorientation, apraxia, ac-
alculia, and memory impairment, lasted for 2 months. Follow-
up MRI performed 50 days after the onset of the cognitive 
impairment showed marked resolution of previous abnormal 
high-signal lesions and a few subtle remaining white-matter 
lesions (Fig. 2). In addition, T2*-weighted gradient-echo MRI 
revealed multiple tiny low-signal lesions distributed over the 
areas where the previous abnormal lesions had been located. 
 
Discussion 
 
Fat embolism syndrome has nonspecific and variable cere-
bral manifestations, including headache, lethargy, irritability, 
convulsions, and coma. Despite the marked neurologic dys-
function in our patient, there were no obvious pulmonary 
symptoms or signs. There are several reports of isolated neu-
rologic disorder occurring after cerebral fat embolism.
7 The 
history of traumatic bone fractures, delayed onset of a non-
focal neurologic dysfunction, the appearance of petechiae 
over the anterior chest, and marked abnormal signals over 
conspicuous sites on MRI supported the diagnosis of cere-
bral fat embolism in this patient. 
Small, scattered, hyperintense lesions on T2WI and FL-
AIR imaging have been found previously.
2-4 These lesions 
typically appear in the periventricular, subcortical, and deep 
white matter, as well as in the deep gray matter, including the 
corpus callosum.
8-10 The lesions are usually not detected by 
CT and are more prominent on DWI than T2WI and FLAIR 
images, especially during the acute stage. These abnormalities 
Fig. 1. Multiple scattered high signals were evident on 
DWI and FLAIR images obtained 10 hours after the on-
set of drowsiness. DWI: diffusion-weighted MRI, FLAIR:
fluid-attenuated inversion recovery. 
Fig. 2. T2WI, FLAIR, and T2*-weighted gradient-echo 
MRI was performed on day 50. Most of the lesions had 
disappeared, but ill-defined high-signal lesions remained 
in the periventricular and subcortical white matter and in 
the cortex. T2*-weighted gradient-echo MRI showed nu-
merous punctate low-signal lesions in the centrum se-
miovale, subcortical white matter, periventricular white 
matter, and corpus callosum. T2WI: T2-weighted imag-
ing, FLAIR: fluid-attenuated inversion recovery.  
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in the signal intensity on DWI presumably reflect the foci of 
cytotoxic edema. Clinical studies by Simon et al. and But-
teriss et al. suggested that focal parenchymal hemorrhage is 
not a predominant feature in T2*-weighted gradient-echo 
MRI.
8,9 However, their cases might not accurately reflect the 
full spectrum of patients with cerebral fat embolism because 
they showed relatively good clinical improvement. The num-
ber of white-matter lesions on MRI is correlated with the 
patient’s score on the Glasgow Coma Scale.
10 Simon et al. 
considered that gradient-echo imaging might be useful in 
determining the severity of cerebral fat embolism, although 
hemorrhage was not a predominant feature of the multiple 
white-matter lesions in their reported case.
9 Neuropsycholo-
gical testing has revealed obvious cognitive deficits in pa-
tients with stenosis of the internal carotid artery and lesions 
on the periventricular, subcortical, and deep white matter.
11 
Periventricular and subcortical white-matter lesions have been 
associated with worse performance on all cognitive measures 
tested.
12 The patient in the present study exhibited continuous 
neurologic impairment, and T2*-weighted gradient-echo MRI 
showed that the lesions were distributed throughout the white 
matter of the cerebrum.   
Reports of serial MRI and gradient-echo MRI in cases of 
cerebral fat embolism are rare. Previous studies of this con-
dition found improvement of the neurologic impairment and 
the gradually disappearance of lesions on MRI within a few 
weeks to a few months. These findings might reflect imme-
diate cytotoxic edema secondary to ischemia and subsequent 
vasogenic edema developing at a later stage.
4 The patient in 
the present study presented with persistent cognitive impair-
ment during the follow-up period. Follow-up MRI (T2WI 
and FLAIR) showed that some lesions disappeared, with only 
subtle ill-defined signal changes remaining. These findings 
did not explain the persistent neurologic impairment. A T2*-
weighted gradient-echo MRI sequence is sensitive to hemo-
siderin deposits in the brain parenchyma and is very useful 
for assessing the presence of old and new hemorrhage.
13,14 
Gradient-echo MRI sequences were not obtained during the 
initial MRI examination in this patient. However, T2*-wei-
ghted gradient-echo MRI in the subacute and chronic stages 
of the follow-up MRI study in this patient revealed promi-
nent multiple low signals, which might explain the residual 
neurologic impairment.   
The findings of the present study suggest that T2*-weight-
ed gradient-echo MRI can be used to analyze the neurologic 
impairment in patients with cerebral fat embolism, with the 
findings also closely reflecting the clinical severity. Gradient-
echo imaging is useful for detecting the petechial hemorr-
hage that is the characteristic pathologic finding of cerebral 
fat embolism. Gradient-echo MRI might be useful in defin-
ing the clinical severity of cerebral fat embolism with diffuse 
petechial lesions in the subacute or chronic stage, especially 
when abnormal signals are not detected in other forms of 
MRI.  
In conclusion, MRI can be used for the early diagnosis of 
cerebral fat embolism with high sensitivity. We suggest that 
T2*-weighted gradient-echo MRI provides useful informat-
ion for determining the clinical severity of patients with cere-
bral fat embolism. 
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